Kamada
Manufacturing · Israel · 201-500 Employees
View Company Info for Free
Overview
Headquarters
2 Holzman Street Science Park, Rehovot, ...Phone Number
+972 89406472Website
www.kamada.comRevenue
$181.7 MillionStock Symbol
KMDAIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
1
1
1
About Kamada
Kamada Ltd. is a commercial-stage biopharmaceutical company specializing in the development, manufacturing, and commercialization of plasma-derived therapeutics for the treatment of rare and serious medical conditions. The company focuses on producing specialty biologic products that address unmet medical needs while providing life-saving therapies for patients affected by immune deficiencies, infectious diseases, pulmonary disorders, and other complex health conditions. Through decades of scientific expertise in plasma-derived technologies, Kamada has established itself as an internationally recognized manufacturer and supplier of specialized therapeutic products distributed across numerous global healthcare markets.Explore more
Kamada Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Kamada your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once Kamada has new funding data
Check if Kamada has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when Kamada launches new products
Congratulate Masked Content for being promoted to Masked Content at Kamada
Earning: See what the market has to say on Kamada recently announced quarterly report
Website visits: Recent activity has been detected on your website
Click to see if Kamada had a recent Job posting/layoffs
Kamada, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if Kamada is spiking on competitors!
Recommended Actions
Find VP level buyers at Kamada
Find 3 more new buyers
Company Profile Activity
Activity Insights
Kamada is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Kamada is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Kamada.
Kamada financials insights
Gather financial insights about Kamada, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2020
Share Placement
$25M
2022
Other Financing Round
$11.4M
Kamada Tech Stack
A closer look at the technologies used by Kamada
See more technologies
Most Recent Scoops
New Hire
Executive Move
Executive Moves, New Hire
Open Position
Seeking Replacement
Hiring Plans
Kamada has more open roles in Operations than it has had at any time in the past 12 months.
Hiring Plans
Hiring Plans
Kamada has more open roles in Medical & Health than it has had at any time in the past 9 months.
Hiring Plans
Earnings
Earnings, Finance
Kamada News & Media
Kamada to Present at the H.C. Wainwright 28th Annual Global Investment Conference
REHOVOT, Israel, and HOBOKEN, N.J., Sept. 10, 2026 (GLOBE NEWSWIRE) -- Kamada Ltd. (NASDAQ: KMDA; TASE: KMDA.TA), a global biopharmaceutical company with a portfolio of marketed products indicated for rare and serious conditions and a leader in the specialty plasma-derived field, today announced that Amir London, Chief Executive Officer, will participate and present at the H.C. Wainwright 28th Annual Global Investment Conference, taking place at the Lotte New York Palace Hotel.Kamada Updates on Withholding Tax Procedures on Previously Announced Cash Dividend to Shareholders
REHOVOT, Israel and HOBOKEN, N.J., Sept. 03, 2026 (GLOBE NEWSWIRE) -- Kamada Ltd. (the “Company”) (NASDAQ: KMDA; TASE: KMDA.TA), a global biopharmaceutical company with a portfolio of marketed products indicated for rare and serious conditions and a leader in the specialty plasma-derived field, announced today that it has obtained a tax ruling (the “Ruling”) from the Israel Tax Authority (the “ITA”) with respect to the cash dividend of $0.17 (approximately NIS 0.51) per share onKamada Declares Cash Dividend of $0.17 Per Share; The Company Reported Record-High Revenue and Profitability for First Six Months of 2026
Dividend to be Paid Consistent with the Company's Cash Dividend Policy Dividend to be Paid Consistent with the Company's Cash Dividend PolicyKamada Ltd. (KMDA) Q2 2026 Earnings Call Transcript
Kamada Ltd. (KMDA) Q2 2026 Earnings Call August 12, 2026 8:30 AM EDTCompany ParticipantsAmir London - Chief Executive OfficerChaime Orlev - Chief Financial...
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Kamada
Sign Up For FreeTo access detailed company insights
Kamada Ltd. is a commercial-stage biopharmaceutical company specializing in the development, manufacturing, and commercialization of plasma-derived therapeutics for the treatment of rare and serious medical conditions. The company focuses on producing specialty biologic products that address unmet medical needs while providing life-saving therapies... Read More
